Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BYFrontiers in medicine

TRPML1 inhibitor ML-SI1 suppresses prostate cancer through dual regulation of androgen receptor and polyamine metabolism

  1. 1Department of Pharmacology, College of Basic Medical Sciences, The Medical Basic Research Innovation Center of Airway Disease in North China, Key Laboratory of Pathobiology, Ministry of Education, Jilin University , ,
  2. 2Department of Cell Biology and Medical Genetics, College of Basic Medical Sciences, Jilin University , ,
  3. 3Department of Histology and Embryology, College of Basic Medical Sciences, Jilin University , ,

Related

  1. Pharmacologic Targeting of ZNF281 Suppresses Metastatic Prostate Cancer Beyond Androgen Receptor Dependence
    G. Huang, M. A. Lorenzana Carrillo, H. Chen +14
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. A bacterial pangenome association study identifies a role for polyamine metabolism and alkaline tolerance in middle ear infections
    Jocelyn A. Hammond, Rachel L. Ehrlich, Ariel Gonzalez +17
    PLOS PathogensPeer-reviewedCC BY 4.0Full textGenetics & genomicsMicrobiologyPLOS
  3. Pharmacologically Targeting DHODH-Dependent Pyrimidine Metabolism with HSA-Conjugated BRQ Suppresses Leukemogenesis
    Xiaoxu Zhang, Changhao Tian, Yang Ding +4
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  4. HIF-1α-driven lactate from mesenchymal stem/stromal cells reprograms monocyte metabolism and suppresses autoimmune uveoretinitis
    Hyun Ju Lee, Jung Hwa Ko, Jin Suk Ryu +1
    Cell ReportsPeer-reviewedCC BY 4.0General medicineCrossref
  5. A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer.
    S. Sridhar, K. Mohan, S. Kizhake +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
BibTeX
@article{li2026trpml1,
  title = {{TRPML1 inhibitor ML-SI1 suppresses prostate cancer through dual regulation of androgen receptor and polyamine metabolism}},
  author = {Jiongzheng Li and Jipeng Ding and Hongfei Wei and Rongrong Ding and Jintong Zhu and Yufei Yan and Yiming Yang and Jia Zhao and Jing Li},
  journal = {Frontiers in medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13654739},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - TRPML1 inhibitor ML-SI1 suppresses prostate cancer through dual regulation of androgen receptor and polyamine metabolism
AU  - Jiongzheng Li
AU  - Jipeng Ding
AU  - Hongfei Wei
AU  - Rongrong Ding
AU  - Jintong Zhu
AU  - Yufei Yan
AU  - Yiming Yang
AU  - Jia Zhao
AU  - Jing Li
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in medicine
UR  - https://europepmc.org/article/PMC/PMC13654739
SN  - 2296-858X
ER  -